Optimal Sparse Descriptor Selection for QSAR Using Bayesian Methods
暂无分享,去创建一个
[1] Anahita Kyani,et al. Application of genetic algorithm-kernel partial least square as a novel nonlinear feature selection method: activity of carbonic anhydrase II inhibitors. , 2007, European journal of medicinal chemistry.
[2] Yu-Dong Cai,et al. Support vector machine for SAR/QSAR of phenethyl-amines , 2007, Acta Pharmacologica Sinica.
[3] Martyn G. Ford,et al. Unsupervised Forward Selection: A Method for Eliminating Redundant Variables , 2000, J. Chem. Inf. Comput. Sci..
[4] Jonathan D. Hirst,et al. Contemporary QSAR Classifiers Compared , 2007, J. Chem. Inf. Model..
[5] David A Winkler,et al. Neural networks as robust tools in drug lead discovery and development , 2004, Molecular biotechnology.
[6] Frank R Burden,et al. Broad-based quantitative structure-activity relationship modeling of potency and selectivity of farnesyltransferase inhibitors using a Bayesian regularized neural network. , 2004, Journal of medicinal chemistry.
[7] Stefan H. Unger,et al. Model building in structure-activity relations. Reexamination of adrenergic blocking activity of .beta.-halo-.beta.-arylalkylamines , 1973 .
[8] Julio Caballero,et al. Modeling of activity of cyclic urea HIV-1 protease inhibitors using regularized-artificial neural networks. , 2006, Bioorganic & medicinal chemistry.
[9] Kimito Funatsu,et al. The Recent Trend in QSAR Modeling - Variable Selection and 3D-QSAR Methods , 2007 .
[10] Paola Gramatica,et al. 3D‐modelling and Prediction by WHIM Descriptors. Part 6. Application of WHIM Descriptors in QSAR Studies , 1997 .
[11] John H. Kalivas,et al. QSAR modeling based on the bias/variance compromise: a harmonious , 2004, J. Comput. Aided Mol. Des..
[12] D. Manallack,et al. Neural networks in drug discovery: Have they lived up to their promise? , 1999 .
[13] David J. Livingstone,et al. The Use of Artificial Neural Networks in QSAR , 1992 .
[14] G Beck,et al. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.
[15] Frank R. Burden,et al. Use of Automatic Relevance Determination in QSAR Studies Using Bayesian Neural Networks , 2000, J. Chem. Inf. Comput. Sci..
[16] Igor V. Tetko,et al. Data modelling with neural networks: Advantages and limitations , 1997, J. Comput. Aided Mol. Des..
[17] Igor V. Pletnev,et al. Drug Discovery Using Support Vector Machines. The Case Studies of Drug-likeness, Agrochemical-likeness, and Enzyme Inhibition Predictions , 2003, J. Chem. Inf. Comput. Sci..
[18] Romualdo Benigni,et al. Predictivity of QSAR , 2008, J. Chem. Inf. Model..
[19] Mário A. T. Figueiredo. Adaptive Sparseness for Supervised Learning , 2003, IEEE Trans. Pattern Anal. Mach. Intell..
[20] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[21] Bahram Hemmateenejad,et al. Genetic Algorithm Applied to the Selection of Factors in Principal Component-Artificial Neural Networks: Application to QSAR Study of Calcium Channel Antagonist Activity of 1, 4-Dihydropyridines (Nifedipine Analogous) , 2003, J. Chem. Inf. Comput. Sci..
[22] Tariq A. Andrea. Novel Structure—Activity Insights from Neural Network Models , 1995 .
[23] Z R Li,et al. Prediction of genotoxicity of chemical compounds by statistical learning methods. , 2005, Chemical research in toxicology.
[24] Johann Gasteiger,et al. Neural networks and genetic algorithms in drug design , 2001 .
[25] Hu Mei,et al. Support vector machine applied in QSAR modelling , 2005 .
[26] D. Livingstone,et al. Structure-activity relationships of antifilarial antimycin analogues: a multivariate pattern recognition study. , 1990, Journal of medicinal chemistry.
[27] David J. C. MacKay,et al. Bayesian Interpolation , 1992, Neural Computation.
[28] Ş. Niculescu. Artificial neural networks and genetic algorithms in QSAR , 2003 .
[29] J. Topliss,et al. Chance correlations in structure-activity studies using multiple regression analysis , 1972 .
[30] Tomas Öberg,et al. A QSAR for Baseline Toxicity: Validation, Domain of Application, and Prediction , 2004 .
[31] Shu-Shen Liu,et al. VSMP: A Novel Variable Selection and Modeling Method Based on the Prediction , 2003, J. Chem. Inf. Comput. Sci..
[32] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[33] Klaus-Robert Müller,et al. Estimating the domain of applicability for machine learning QSAR models: a study on aqueous solubility of drug discovery molecules , 2007, J. Comput. Aided Mol. Des..
[34] M. Karplus,et al. Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors. , 1996, Journal of medicinal chemistry.
[35] Angelo Carotti,et al. QSAR and QSPR Studies of a Highly Structured Physicochemical Domain , 2006, J. Chem. Inf. Model..
[36] Paola Gramatica,et al. Principles of QSAR models validation: internal and external , 2007 .
[37] L Xue,et al. Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening. , 2000, Combinatorial chemistry & high throughput screening.
[38] R. Boggia,et al. Genetic algorithms as a strategy for feature selection , 1992 .
[39] M Karplus,et al. Evolutionary optimization in quantitative structure-activity relationship: an application of genetic neural networks. , 1996, Journal of medicinal chemistry.
[40] Irina G. Tsygankova,et al. Variable Selection in QSAR Models for Drug Design , 2008 .
[41] F. Burden,et al. Robust QSAR models using Bayesian regularized neural networks. , 1999, Journal of medicinal chemistry.
[42] Martyn G. Ford,et al. The structure/activity relationships of pyrethroid insecticides. 1. A Novel Approach Based upon the Use of Multivariate QSAR and Computational Chemistry , 1989 .
[43] Frank R. Burden,et al. Predictive Human Intestinal Absorption QSAR Models Using Bayesian Regularized Neural Networks , 2005 .
[44] Walters Wp,et al. Feature selection in quantitative structure-activity relationships. , 2005 .
[45] Walter Cedeño,et al. On the Use of Neural Network Ensembles in QSAR and QSPR , 2002, J. Chem. Inf. Comput. Sci..